Adial Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.88 Insider Own5.10% Shs Outstand23.15M Perf Week0.84%
Market Cap29.54M Forward P/E- EPS next Y-0.54 Insider Trans2.03% Shs Float20.62M Perf Month-5.51%
Income-17.50M PEG- EPS next Q-0.17 Inst Own13.20% Short Float4.01% Perf Quarter-40.30%
Sales- P/S- EPS this Y-19.60% Inst Trans52.59% Short Ratio3.91 Perf Half Y-55.06%
Book/sh0.46 P/B2.61 EPS next Y78.10% ROA-175.20% Target Price10.67 Perf Year-52.57%
Cash/sh0.52 P/C2.33 EPS next 5Y- ROE-266.70% 52W Range1.04 - 5.08 Perf YTD-55.56%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-76.38% Beta0.80
Dividend %- Quick Ratio6.00 Sales past 5Y- Gross Margin- 52W Low15.52% ATR0.14
Employees16 Current Ratio6.00 Sales Q/Q- Oper. Margin- RSI (14)43.78 Volatility13.29% 11.71%
OptionableYes Debt/Eq0.00 EPS Q/Q58.70% Profit Margin- Rel Volume1.28 Prev Close1.34
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume211.10K Price1.20
Recom2.00 SMA20-8.19% SMA50-11.76% SMA200-49.91% Volume269,814 Change-10.45%
Oct-30-18Initiated Maxim Group Buy $5
Oct-11-18Initiated Dawson James Buy
Jun-28-22 11:49AM  
Jun-27-22 09:16AM  
Jun-14-22 10:48AM  
May-19-22 09:25AM  
May-16-22 09:25AM  
May-05-22 04:05PM  
May-04-22 09:15AM  
Apr-06-22 07:47AM  
Mar-22-22 09:15AM  
Feb-24-22 09:15AM  
Feb-16-22 09:26AM  
Feb-11-22 09:00AM  
Feb-09-22 09:25AM  
Jan-24-22 09:25AM  
Jan-12-22 09:40AM  
Jan-10-22 09:03AM  
Dec-22-21 09:25AM  
Dec-08-21 09:25AM  
Nov-29-21 09:00AM  
Nov-17-21 09:42AM  
Nov-10-21 09:26AM  
Nov-09-21 09:15AM  
Nov-03-21 09:10AM  
Oct-21-21 01:06PM  
Oct-18-21 09:30AM  
Oct-05-21 09:25AM  
Oct-04-21 04:30PM  
Sep-30-21 09:25AM  
Sep-28-21 09:49AM  
Sep-15-21 10:07AM  
Sep-13-21 09:30AM  
Sep-07-21 09:00AM  
Aug-31-21 09:30AM  
Aug-20-21 10:45AM  
Aug-12-21 02:50PM  
Aug-10-21 09:30AM  
Aug-05-21 10:12AM  
Jul-29-21 09:30AM  
Jul-14-21 02:00PM  
Jul-07-21 10:11AM  
Jul-06-21 09:25AM  
Jun-28-21 09:45AM  
Jun-25-21 09:02AM  
Jun-24-21 05:07PM  
Jun-22-21 09:55AM  
Jun-07-21 09:30AM  
Jun-03-21 09:54AM  
May-18-21 01:19PM  
Apr-07-21 11:09AM  
Mar-23-21 09:00AM  
Mar-17-21 10:00AM  
Mar-15-21 09:30AM  
Feb-26-21 03:05PM  
Feb-25-21 09:30AM  
Feb-23-21 01:00PM  
Jan-26-21 10:15AM  
Jan-11-21 11:00AM  
Dec-17-20 09:45AM  
Dec-15-20 09:30AM  
Dec-10-20 12:10PM  
Dec-09-20 11:25AM  
Dec-04-20 09:30AM  
Nov-25-20 12:20PM  
Nov-16-20 05:33AM  
Nov-03-20 09:50AM  
Oct-22-20 09:30AM  
Oct-21-20 09:30AM  
Sep-30-20 09:25AM  
Sep-29-20 09:30AM  
Sep-25-20 10:00AM  
Sep-22-20 09:30AM  
Sep-09-20 09:00AM  
Sep-01-20 07:22PM  
Aug-31-20 05:00PM  
Aug-06-20 09:30AM  
Aug-05-20 09:00AM  
Jul-28-20 09:30AM  
Jul-22-20 09:45AM  
Jul-06-20 08:15AM  
Jun-25-20 09:30AM  
Jun-17-20 09:55AM  
Jun-15-20 09:30AM  
Jun-11-20 11:35AM  
Jun-10-20 10:06AM  
Jun-09-20 09:15AM  
Jun-08-20 09:30AM  
May-28-20 09:30AM  
May-04-20 10:15AM  
Apr-23-20 08:45AM  
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Newman James W. Jr.DirectorDec 30Buy2.7115,00040,70050,221Jan 03 10:39 AM
Newman James W. Jr.DirectorDec 30Buy2.6610,00026,60020,000Jan 03 10:39 AM
Stilley William B. IIIChief Executive OfficerNov 30Buy2.7510,60029,179937,646Dec 01 09:25 AM
Stilley William B. IIIChief Executive OfficerNov 29Buy2.5910,00025,892927,046Dec 01 09:25 AM
Newman James W. Jr.DirectorNov 26Buy2.8510,00028,50034,475Nov 30 09:25 AM